Other Species / Isoforms
  GATA2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S71-p
AHARARVsYsPAHAR
Upstream
0 1
Treatment
  • MLN8054
GATA2 (human) AHARARVsYsPAHAR S71-p
GATA2 (mouse) AHARARVSYsPAHAR S71
GATA2 (rat) AHARARVSYSPAHAR S71
S73-p
ARARVsYsPAHARLT
1 6
GATA2 (human) ARARVsYsPAHARLT S73-p
GATA2 (mouse) ARARVSYsPAHARLT S73-p
GATA2 (rat) ARARVSYSPAHARLT S73
R86-m2
LTGGQMCrPHLLHSP
0 2
GATA2 (human) LTGGQMCrPHLLHSP R86-m2
GATA2 (mouse) LTGGQMCRPHLLHSP R86
GATA2 (rat) LTGGQMCRPHLLHSP R86
S119-p
HHNPWTVsPFSKTPL
1 1
GATA2 (human) HHNPWTVsPFSKTPL S119-p
GATA2 (mouse) HHSPWTVSPFSKTPL S119
GATA2 (rat) HHSPWTVSPFSKTPL S119
T176-p
HLFGFPPtPPKEVsP
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
GATA2 (human) HLFGFPPtPPKEVsP T176-p
GATA2 (mouse) HLFGFPPTPPKEVSP T176
GATA2 (rat) HLFGFPPTPPKEVSP T176
S182-p
PtPPKEVsPDPsTTG
0 3
GATA2 (human) PtPPKEVsPDPsTTG S182-p
GATA2 (mouse) PTPPKEVSPDPSTTG S182
GATA2 (rat) PTPPKEVSPDPSTTG S182
S186-p
KEVsPDPsTTGAAsP
0 1
GATA2 (human) KEVsPDPsTTGAAsP S186-p
GATA2 (mouse) KEVSPDPSTTGAAsP S186
GATA2 (rat) KEVSPDPSTTGAASP S186
S192-p
PsTTGAAsPASSSAG
Upstream
Downstream
2 6
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • transcription, induced
Putative in vivo kinases:
  • P38A (human)
Treatment
  • mutation
  • okadaic_acid
  • SB203580
  • siRNA
GATA2 (human) PsTTGAAsPASSSAG S192-p
GATA2 (mouse) PSTTGAAsPASSSAG S192-p
GATA2 (rat) PSTTGAASPASPSAG S192
Y213-p
EDKDGVKyQVsLTEs
0 1
GATA2 (human) EDKDGVKyQVsLTEs Y213-p
GATA2 (mouse) EDKDGVKYQVSLSES Y213
GATA2 (rat) EDKDGVKYQVSLSES Y213
S216-p
DGVKyQVsLTEsMKM
0 1
GATA2 (human) DGVKyQVsLTEsMKM S216-p
GATA2 (mouse) DGVKYQVSLSESMKM S216
GATA2 (rat) DGVKYQVSLSESMKM S216
S220-p
yQVsLTEsMKMESGS
0 1
GATA2 (human) yQVsLTEsMKMESGS S220-p
GATA2 (mouse) YQVSLSESMKMEGGS S220
GATA2 (rat) YQVSLSESMKMEGGS S220
S276-p
GFLGGPAsSFTPKQR
0 1
GATA2 (human) GFLGGPAsSFTPKQR S276-p
GATA2 (mouse) GFLGGPASSFTPKQR S276
GATA2 (rat) GFLGGPASSFTPKQR S276
S290-p
RSKARSCsEGRECVN
1 2
GATA2 (human) RSKARSCsEGRECVN S290-p
GATA2 (mouse) RSKARSCSEGRECVN S290
GATA2 (rat) RSKARSCSEGRECVN S290
Y314-p
RRDGTGHyLCNACGL
0 2
GATA2 (human) RRDGTGHyLCNACGL Y314-p
GATA2 (mouse) RRDGTGHYLCNACGL Y314
GATA2 (rat) RRDGTGHYLCNACGL Y314
Y322-p
LCNACGLyHKMNGQN
0 3
GATA2 (human) LCNACGLyHKMNGQN Y322-p
GATA2 (mouse) LCNACGLYHKMNGQN Y322
GATA2 (rat) LCNACGLYHKMNGQN Y322
K389-sm
VNRPLTMkKEGIQTR
0 1
GATA2 (human) VNRPLTMkKEGIQTR K389-sm
GATA2 (mouse) VNRPLTMKkEGIQTR K389
GATA2 (rat) VNRPLTMKKEGIQTR K389
K390
NRPLTMkKEGIQTRN
0 1
GATA2 (human) NRPLTMkKEGIQTRN K390
GATA2 (mouse) NRPLTMKkEGIQTRN K390-ac
GATA2 (rat) NRPLTMKKEGIQTRN K390
S401-p
QTRNRKMsNKSKKSK
Upstream
Downstream
1 5
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
Effects on Biological Processes:
  • cell growth, altered
  • transcription, altered
Kinase, in vitro:
  • Akt1 (human)
Treatment
  • insulin
  • wortmannin
GATA2 (human) QTRNRKMsNKSKKSK S401-p
GATA2 (mouse) QTRNRKMsSKSKKSK S401-p
GATA2 (rat) QTRNRKMSSKSKKSK S401
K409-ub
NKSKKSKkGAECFEE
0 1
GATA2 (human) NKSKKSKkGAECFEE K409-ub
GATA2 (mouse) SKSKKSKKGAECFEE K409
GATA2 (rat) SKSKKSKKGAECFEE K409